5-aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders
US5436252A · kind A · utility
27Cited by
3References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 1990 |
| Grant date | Jul 25, 1995 |
| Priority date | — |
| Expiry date | Mar 15, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D249/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to neuroprotective 5-aryl-3H-1,2,4-triazol-3-ones and to their use in the treatment of neurodegenerative disorders such as cerebral ischemia, stroke, Alzheimer's disease, Parkinson's disease, and Huntington's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.